166 related articles for article (PubMed ID: 22044862)
1. A prospective comparison of cardiac magnetic resonance imaging and radionuclide ventriculography in the assessment of cardiac function in patients treated with anthracycline-based chemotherapy.
Sipola P; Vanninen E; Jantunen E; Nousiainen T; Kiviniemi M; Hartikainen J; Kuittinen T
Nucl Med Commun; 2012 Jan; 33(1):51-9. PubMed ID: 22044862
[TBL] [Abstract][Full Text] [Related]
2. Radionuclide ventriculography detects early anthracycline cardiotoxicity in children with Hodgkin lymphoma.
Tantawy AA; Elmasry OA; Shaaban M; Toaima DN; El Shahat AM
J Pediatr Hematol Oncol; 2011 May; 33(4):e132-7. PubMed ID: 21516011
[TBL] [Abstract][Full Text] [Related]
3. Comparison of echocardiography and radionuclide ventriculography in the follow-up of left ventricular systolic function in adult lymphoma patients during doxorubicin therapy.
Nousiainen T; Vanninen E; Jantunen E; Puustinen J; Remes J; Rantala A; Hartikainen J
J Intern Med; 2001 Apr; 249(4):297-303. PubMed ID: 11298849
[TBL] [Abstract][Full Text] [Related]
4. Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy.
Blaes AH; Rehman A; Vock DM; Luo X; Menge M; Yee D; Missov E; Duprez D
Vasc Health Risk Manag; 2015; 11():591-4. PubMed ID: 26648730
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients.
Nousiainen T; Vanninen E; Jantunen E; Remes J; Ritanen E; Vuolteenaho O; Hartikainen J
Clin Sci (Lond); 2001 Dec; 101(6):601-7. PubMed ID: 11724646
[TBL] [Abstract][Full Text] [Related]
6. Concomitant impairment of left ventricular systolic and diastolic function during doxorubicin therapy: a prospective radionuclide ventriculographic and echocardiographic study.
Nousiainen T; Vanninen E; Jantunen E; Puustinen J; Remes J; Rantala A; Hartikainen J
Leuk Lymphoma; 2002 Sep; 43(9):1807-11. PubMed ID: 12685836
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy.
Tsai HR; Gjesdal O; Wethal T; Haugaa KH; Fosså A; Fosså SD; Edvardsen T
Am J Cardiol; 2011 Feb; 107(3):472-7. PubMed ID: 21257017
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular function in patients with toxic cardiomyopathy and with idiopathic dilated cardiomyopathy treated with Doxorubicin.
Katamadze NA; Lartsuliani KP; Kiknadze MP
Georgian Med News; 2009 Jan; (166):43-8. PubMed ID: 19202217
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive monitoring of cardiac hemodynamic parameters in doxorubicin-treated patients: comparison with echocardiography.
Villani F; Meazza R; Materazzo C
Anticancer Res; 2006; 26(1B):797-801. PubMed ID: 16739356
[TBL] [Abstract][Full Text] [Related]
10. Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy.
Kang Y; Xu X; Cheng L; Li L; Sun M; Chen H; Pan C; Shu X
Eur J Heart Fail; 2014 Mar; 16(3):300-8. PubMed ID: 24464946
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma.
Nousiainen T; Jantunen E; Vanninen E; Remes J; Vuolteenaho O; Hartikainen J
Eur J Haematol; 1999 Feb; 62(2):135-41. PubMed ID: 10052718
[TBL] [Abstract][Full Text] [Related]
12. Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients.
Nousiainen T; Jantunen E; Vanninen E; Hartikainen J
Br J Cancer; 2002 Jun; 86(11):1697-700. PubMed ID: 12087452
[TBL] [Abstract][Full Text] [Related]
13. Continuing routine cardiac surveillance in long-term use of pegylated liposomal doxorubicin: is it necessary?
Gill SE; Savage K; Wysham WZ; Blackhurst DW; Winter WE; Puls LE
Gynecol Oncol; 2013 Jun; 129(3):544-7. PubMed ID: 23523653
[TBL] [Abstract][Full Text] [Related]
14. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
[TBL] [Abstract][Full Text] [Related]
15. Cardiac magnetic resonance imaging for the assessment of the myocardium after doxorubicin-based chemotherapy.
Lunning MA; Kutty S; Rome ET; Li L; Padiyath A; Loberiza F; Bociek RG; Bierman PJ; Vose JM; Armitage JO; Porter TR
Am J Clin Oncol; 2015 Aug; 38(4):377-81. PubMed ID: 24192805
[TBL] [Abstract][Full Text] [Related]
16. Myocyte cell damage after administration of doxorubicin or mitoxantrone in breast cancer patients assessed by indium 111 antimyosin monoclonal antibody studies.
Estorch M; Carrió I; Martínez-Duncker D; Berná L; Torres G; Alonso C; Ojeda B
J Clin Oncol; 1993 Jul; 11(7):1264-8. PubMed ID: 8315423
[TBL] [Abstract][Full Text] [Related]
17. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
Konstam MA; Patten RD; Thomas I; Ramahi T; La Bresh K; Goldman S; Lewis W; Gradman A; Self KS; Bittner V; Rand W; Kinan D; Smith JJ; Ford T; Segal R; Udelson JE
Am Heart J; 2000 Jun; 139(6):1081-7. PubMed ID: 10827391
[TBL] [Abstract][Full Text] [Related]
18. Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.
Kuittinen T; Jantunen E; Vanninen E; Mussalo H; Vuolteenaho O; Ala-Kopsala M; Nousiainen T; Hartikainen J
Eur J Haematol; 2006 Aug; 77(2):120-7. PubMed ID: 16856907
[TBL] [Abstract][Full Text] [Related]
19. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.
Cardinale D; Colombo A; Bacchiani G; Tedeschi I; Meroni CA; Veglia F; Civelli M; Lamantia G; Colombo N; Curigliano G; Fiorentini C; Cipolla CM
Circulation; 2015 Jun; 131(22):1981-8. PubMed ID: 25948538
[TBL] [Abstract][Full Text] [Related]
20. [Changes in left ventricular function during chemotherapy with doxorubicin].
Elbl L; Chaloupka V; Vásová I; Kiss I; Jancík J; Vorlícek J; Navrátil M
Vnitr Lek; 1999 Jul; 45(7):395-402. PubMed ID: 11045157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
